Fortress Biotech Announces Closing of $10.0 Million Public Offering - Fortress Biotech (NASDAQ:FBIO)

MIAMI, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress" or "Company"), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or

Related Keywords

Miami ,Florida ,United States ,Tony Plohoros ,Jaclyn Jaffe ,Company Contact ,Roth Capital Partners ,Jude Children Research Hospital ,Fortress Or Company ,Fred Hutchinson Cancer Center ,Fortress Biotech Inc ,Astrazeneca ,Exchange Commission ,Securities Exchange ,Capital Partners ,Clemente Drive ,Newport Beach ,Jude Children ,Research Hospital ,Nationwide Children ,Securities Act ,Securities Exchange Act ,Annual Report ,Private Securities Litigation Reform Act ,Relations Contact ,